Because SIRT2 has been shown to increase α-synuclein aggregation, exacerbate oxidative stress damage, decrease microtubule stability, and aggravate neuroinflammation in different PD models [48], the SRT1720-mediated suppression of PQ-induced SIRT2 expression could be a protective mechanism. This evidence concerns the gene SIRT2 and Parkinson disease.